Aquestive Therapeutics, Inc. AQST Deferred Tax Liabilities, Right Of Use Assets
Deferred Tax Liabilities, Right Of Use Assets at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept aqst:DeferredTaxLiabilitiesRightOfUseAssets.
The official record: Aquestive Therapeutics, Inc.’s 10-K, filed March 4, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s deferred tax liabilities, right of use assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s deferred tax liabilities, right of use assets?
- Aquestive Therapeutics, Inc. (AQST) reported deferred tax liabilities, right of use assets of $1.16M in Q4 2025.
- What does deferred tax liabilities, right of use assets mean?
- This represents the deferred tax liability arising from the difference between the book value of right-of-use assets under lease accounting standards and their tax basis. It reflects the future tax payments expected as the lease asset is amortized for financial reporting purposes differently than for tax purposes. This metric is important for understanding the tax impact of lease obligations on the balance sheet.